MIDDLE EAST AND AFRICA BIOSURGERY MARKET 2021-2028

Lifesciences | Medical Devices & Consumables

MIDDLE EAST AND AFRICA BIOSURGERY MARKET 2021-2028

Market by Product, Application, Source Type, and Country | Forecast 2021-2028

Request For Customization

Request Custom Report

Request Custom Report

Enquire before buying

Enquire Before Buying

As stated in Triton’s report, the biosurgery market in the Middle East and Africa is likely to register growth based on revenue at a CAGR of 7.19% over the projected phase 2021-2028.


Report scope can be customized per your requirements. Request For Customization

The countries considered for analysis in this market are:

•        The United Arab Emirates

•        Turkey

•        South Africa

•        Saudi Arabia

•        Rest of Middle East & Africa

The region’s growth is influenced by the surge in the incidence rate of hip fractures, along with increasing healthcare expenditure. Furthermore, the growing aging population adds to the studied market’s growth across the region. In Saudi Arabia, in recent years, there has been significant growth in the number of people over the age of 65, which is likely to proliferate by 2050. This increase is estimated to increase the incidence rate of chronic diseases, influencing the demand for biosurgery products. Additionally, the launch of new products is expected to boost the demand for biosurgery products. Hence, the rising burden of chronic diseases, the growing geriatric population, and new product launches are anticipated to drive the growth of the biosurgery market within Saudi Arabia.

Likewise, the rising chronic diseases have enhanced the number of surgical procedures across the UAE. Thus, the patient pool for chronic conditions is expected to increase the demand for biosurgery products. Additionally, the growing occurrence of cancer is likely to increase the number of surgeries, adding to the growth of the studied market. Besides, in recent years, bariatric surgeries have gained traction across the country, influencing the demand for biosurgery products, leading to the growth of the biosurgery market in the United Arab Emirates.

Baxter International Inc is a healthcare company offering a wide range of healthcare products for chronic dialysis therapies, infusion systems, inhaled aesthetics, parenteral nutrition, surgical hemostat, and others. The company provides its products to hospitals, nursing homes, rehabilitation centers, and kidney dialysis centers. Besides, it markets its offering through a direct sales force, independent distributors, and specialty pharmacies. Baxter has operations across multiple regions, including the Middle East and Africa. 

Related Reports

ASIA PACIFIC AESTHETIC LASER MARKET 2019-2027
Lifesciences

ASIA PACIFIC AESTHETIC LASER MARKET 2019-2027

Market By Type, Application, E ..

VIEW REPORT
ASIA PACIFIC BIOCHIPS MARKET 2019-2027
Lifesciences

ASIA PACIFIC BIOCHIPS MARKET 2019-2027

Market By Type, Substrate Mate ..

VIEW REPORT
ASIA PACIFIC BIOPSY DEVICE MARKET 2019-2027
Lifesciences

ASIA PACIFIC BIOPSY DEVICE MARKET 2019-2027

Market By Device Type, Therape ..

VIEW REPORT
ASIA PACIFIC DNA VACCINES MARKET 2019-2027
Lifesciences

ASIA PACIFIC DNA VACCINES MARKET 2019-2027

Market By Type, Application, T ..

VIEW REPORT
ASIA-PACIFIC 3D CELL CULTURE MARKET 2019-2027
Lifesciences

ASIA-PACIFIC 3D CELL CULTURE MARKET 2019-2027

Market By Technology, Applicat ..

VIEW REPORT
ASIA-PACIFIC AIRWAY CLEARANCE SYSTEM MARKET 2019-2028
Lifesciences

ASIA-PACIFIC AIRWAY CLEARANCE SYSTEM MARKET 2019-2028

Market By Application, Type, E ..

VIEW REPORT

Table of Content

1. MIDDLE EAST AND AFRICA BIOSURGERY MARKET – SUMMARY

2. INDUSTRY OUTLOOK

2.1. IMPACT OF COVID-19 ON BIOSURGERY MARKET

2.2. TRENDS IN BIOSURGERY TECHNOLOGY

2.3. KEY INSIGHTS

2.4. PORTER’S FIVE FORCES MODEL

2.4.1. THREAT OF NEW ENTRANTS

2.4.2. THREAT OF SUBSTITUTE PRODUCTS

2.4.3. BARGAINING POWER OF BUYERS

2.4.4. BARGAINING POWER OF SUPPLIERS

2.4.5. COMPETITIVE RIVALRY

2.5. MARKET ATTRACTIVENESS INDEX

2.6. VENDOR SCORECARD

2.7. KEY BUYING OUTLOOK

2.8. KEY MARKET STRATEGIES

2.8.1. CONTRACTS AND PARTNERSHIPS

2.8.2. BUSINESS EXPANSIONS, ANNOUNCEMENTS, & DIVESTITURES

2.8.3. ACQUISITIONS & MERGERS

2.8.4. NEW PRODUCT LAUNCHES & DEVELOPMENTS

2.9. MARKET DRIVERS

2.9.1. GROWING AGING POPULATION

2.9.2. SURGE IN SURGICAL TREATMENTS FOR MUSCULOSKELETAL DISORDERS

2.9.3. PREVALENCE OF SPINAL FUSION AND JOINT RECONSTRUCTION

2.9.4. STRONG FOCUS ON RESEARCH AND DEVELOPMENT

2.10. MARKET CHALLENGES

2.10.1. HIGH COST OF SURGERIES

2.10.2. COMPLICATIONS RELATED TO IMMUNE RESPONSE

2.10.3. USAGE OF MINIMALLY INVASIVE SURGERIES

2.11. MARKET OPPORTUNITIES

2.11.1. RESEARCH AND INVESTMENTS IN BIOENGINEERING

2.11.2. DEVELOPMENT OF POLICIES FOR REIMBURSEMENT AND COMPENSATION

3. MIDDLE EAST AND AFRICA BIOSURGERY MARKET – BY PRODUCT

3.1. HEMOSTATIC AGENTS

3.2. BONE-GRAFT SUBSTITUTES

3.2.1. SYNTHETIC GRAFT EXTENDERS

3.2.2. DEMINERALIZED BONE MATRIX

3.2.3. BONE MORPHOGENETIC PROTEINS

3.2.4. CELL-BASED MATRICES

3.3. SURGICAL SEALING AGENTS

3.3.1. NATURAL

3.3.2. SYNTHETIC

3.4. SOFT-TISSUE MANAGEMENT

3.4.1. SYNTHETIC MESH/PATCH

3.4.2. NATURAL MESH/PATCH

3.5. ANTI-ADHESIVE AGENTS

3.6. STAPLE LINE REINFORCEMENT

4. MIDDLE EAST AND AFRICA BIOSURGERY MARKET - BY APPLICATION

4.1. ORTHOPEDIC SURGERY

4.2. CARDIO AND THORACIC SURGERY

4.3. NEURO AND SPINE SURGERY

4.4. GENERAL SURGERY

4.5. OTHER APPLICATIONS

5. MIDDLE EAST AND AFRICA BIOSURGERY MARKET – BY SOURCE TYPE

5.1. NATURAL

5.2. SYNTHETIC

6. MIDDLE EAST AND AFRICA BIOSURGERY MARKET – COUNTRY OUTLOOK

6.1. COUNTRY ANALYSIS

6.1.1. SAUDI ARABIA

6.1.2. UNITED ARAB EMIRATES

6.1.3. TURKEY

6.1.4. SOUTH AFRICA

6.1.5. REST OF MIDDLE EAST & AFRICA

7. COMPETITIVE LANDSCAPE

7.1. BAXTER INTERNATIONAL INC

7.2. BECTON, DICKINSON AND COMPANY

7.3. B BRAUN MELSUNGEN AG

7.4. CSL LIMITED

7.5. ETHICON INC (JOHNSON & JOHNSON)

7.6. INTEGRA LIFESCIENCES HOLDINGS CORPORATION

7.7. MEDTRONIC PLC

7.8. RTI SURGICAL

7.9. SANOFI

7.10. SMITH & NEPHEW PLC

7.11. STRYKER CORPORATION

7.12. WRIGHT MEDICAL GROUP NV

7.13. ZIMMER BIOMET HOLDINGS INC

8. RESEARCH METHODOLOGY & SCOPE

8.1. RESEARCH SCOPE & DELIVERABLES

8.1.1. OBJECTIVES OF STUDY

8.1.2. SCOPE OF STUDY

8.2. SOURCES OF DATA

8.2.1. PRIMARY DATA SOURCES

8.2.2. SECONDARY DATA SOURCES

8.3. RESEARCH METHODOLOGY

8.3.1. EVALUATION OF PROPOSED MARKET

8.3.2. IDENTIFICATION OF DATA SOURCES

8.3.3. ASSESSMENT OF MARKET DETERMINANTS

8.3.4. DATA COLLECTION

8.3.5. DATA VALIDATION & ANALYSIS

List of Tables

TABLE 1:       MIDDLE EAST AND AFRICA BIOSURGERY MARKET, COUNTRY OUTLOOK, 2021-2028 (IN $ MILLION)

TABLE 2:       VENDOR SCORECARD

TABLE 3:       CONTRACTS AND PARTNERSHIPS

TABLE 4:       BUSINESS EXPANSIONS, ANNOUNCEMENTS, & DIVESTITURES

TABLE 5:       ACQUISITIONS & MERGERS

TABLE 6:       NEW PRODUCT LAUNCHES & DEVELOPMENTS

TABLE 7:       MIDDLE EAST AND AFRICA BIOSURGERY MARKET, BY PRODUCT, 2021-2028 (IN $ MILLION)

TABLE 8:       MIDDLE EAST AND AFRICA BONE-GRAFT SUBSTITUTES MARKET, BY TYPE, 2021-2028 (IN $ MILLION)

TABLE 9:       MIDDLE EAST AND AFRICA SURGICAL SEALING AGENTS MARKET, BY TYPE, 2021-2028 (IN $ MILLION)

TABLE 10:     MIDDLE EAST AND AFRICA SOFT-TISSUE MANAGEMENT MARKET, BY TYPE, 2021-2028 (IN $ MILLION)

TABLE 11:     MIDDLE EAST AND AFRICA BIOSURGERY MARKET, BY APPLICATION, 2021-2028 (IN $ MILLION)

TABLE 12:     MIDDLE EAST AND AFRICA BIOSURGERY MARKET, BY SOURCE TYPE, 2021-2028 (IN $ MILLION)

TABLE 13:     MIDDLE EAST AND AFRICA BIOSURGERY MARKET, COUNTRY OUTLOOK, 2021-2028 (IN $ MILLION)

List of Figures

FIGURE 1:     MIDDLE EAST AND AFRICA BIOSURGERY MARKET 2021-2028 (IN $ MILLION)

FIGURE 2:     MIDDLE EAST AND AFRICA BIOSURGERY MARKET, BY PRODUCT, 2020 & 2028 (IN %)

FIGURE 3:     MIDDLE EAST AND AFRICA BIOSURGERY MARKET, BY HEMOSTATIC AGENTS, 2021-2028 (IN $ MILLION)

FIGURE 4:     MIDDLE EAST AND AFRICA BIOSURGERY MARKET, BY BONE-GRAFT SUBSTITUTES, 2021-2028 (IN $ MILLION)

FIGURE 5:     MIDDLE EAST AND AFRICA BONE-GRAFT SUBSTITUTES MARKET, BY SYNTHETIC GRAFT EXTENDERS, 2021-2028 (IN $ MILLION)

FIGURE 6:     MIDDLE EAST AND AFRICA BONE-GRAFT SUBSTITUTES MARKET, BY DEMINERALIZED BONE MATRIX, 2021-2028 (IN $ MILLION)

FIGURE 7:     MIDDLE EAST AND AFRICA BONE-GRAFT SUBSTITUTES MARKET, BY BONE MORPHOGENETIC PROTEINS, 2021-2028 (IN $ MILLION)

FIGURE 8:     MIDDLE EAST AND AFRICA BONE-GRAFT SUBSTITUTES MARKET, BY CELL-BASED MATRICES, 2021-2028 (IN $ MILLION)

FIGURE 9:     MIDDLE EAST AND AFRICA BIOSURGERY MARKET, BY SURGICAL SEALING AGENTS, 2021-2028 (IN $ MILLION)

FIGURE 10:  MIDDLE EAST AND AFRICA SURGICAL SEALING AGENTS MARKET, BY NATURAL, 2021-2028 (IN $ MILLION)

FIGURE 11:  MIDDLE EAST AND AFRICA SURGICAL SEALING AGENTS MARKET, BY SYNTHETIC, 2021-2028 (IN $ MILLION)

FIGURE 12:  MIDDLE EAST AND AFRICA BIOSURGERY MARKET, BY SOFT-TISSUE MANAGEMENT, 2021-2028 (IN $ MILLION)

FIGURE 13:  MIDDLE EAST AND AFRICA SOFT-TISSUE MANAGEMENT MARKET, BY SYNTHETIC MESH/PATCH, 2021-2028 (IN $ MILLION)

FIGURE 14:  MIDDLE EAST AND AFRICA SOFT-TISSUE MANAGEMENT MARKET, BY NATURAL MESH/PATCH, 2021-2028 (IN $ MILLION)

FIGURE 15:  MIDDLE EAST AND AFRICA BIOSURGERY MARKET, BY ANTI-ADHESIVE AGENTS, 2021-2028 (IN $ MILLION)

FIGURE 16:  MIDDLE EAST AND AFRICA BIOSURGERY MARKET, BY STAPLE LINE REINFORCEMENT, 2021-2028 (IN $ MILLION)

FIGURE 17:  MIDDLE EAST AND AFRICA BIOSURGERY MARKET, BY APPLICATION, 2020 & 2028 (IN %)

FIGURE 18:  MIDDLE EAST AND AFRICA BIOSURGERY MARKET, BY ORTHOPEDIC SURGERY, 2021-2028 (IN $ MILLION)

FIGURE 19:  MIDDLE EAST AND AFRICA BIOSURGERY MARKET, BY CARDIO AND THORACIC SURGERY, 2021-2028 (IN $ MILLION)

FIGURE 20:  MIDDLE EAST AND AFRICA BIOSURGERY MARKET, BY NEURO AND SPINE SURGERY, 2021-2028 (IN $ MILLION)

FIGURE 21:  MIDDLE EAST AND AFRICA BIOSURGERY MARKET, BY GENERAL SURGERY, 2021-2028 (IN $ MILLION)

FIGURE 22:  MIDDLE EAST AND AFRICA BIOSURGERY MARKET, BY OTHER APPLICATIONS, 2021-2028 (IN $ MILLION)

FIGURE 23:  MIDDLE EAST AND AFRICA BIOSURGERY MARKET, BY SOURCE TYPE, 2020 & 2028 (IN %)

FIGURE 24:  MIDDLE EAST AND AFRICA BIOSURGERY MARKET, BY NATURAL, 2021-2028 (IN $ MILLION)

FIGURE 25:  MIDDLE EAST AND AFRICA BIOSURGERY MARKET, BY SYNTHETIC, 2021-2028 (IN $ MILLION)

FIGURE 26:  SAUDI ARABIA BIOSURGERY MARKET 2021-2028 (IN $ MILLION)

FIGURE 27:  UNITED ARAB EMIRATES BIOSURGERY MARKET 2021-2028 (IN $ MILLION)

FIGURE 28:  TURKEY BIOSURGERY MARKET 2021-2028 (IN $ MILLION)

FIGURE 29:  SOUTH AFRICA BIOSURGERY MARKET 2021-2028 (IN $ MILLION)

FIGURE 30:  REST OF MIDDLE EAST & AFRICA BIOSURGERY MARKET 2021-2028 (IN $ MILLION)

Purchase Options

  • Licence Type
  • Price
  • User/Sharing
  • Printing
  • Delivery Formats
  • Free customization (Pre-sale)
  • Analyst hour support (Post Sale)
  • Customized notification for newly published report
  • Free report on update (within 180 days)

Single User PDF

$1,500.00

  • User/Sharing
  • Restricted to one authorized user
  • Printing
  • Not printable
  • Delivery Formats
  • Pdf
  • Free customization (Pre-sale)
  • 10% Free customization
  • Analyst hour support (Post Sale)
  • 3 hours
  • Customized notification (newly published)
  • Free report on update (within 180 days)

Enterprise Online/PDF

$2,200.00

  • User/Sharing
  • Unlimited
  • Printing
  • Unlimited
  • Delivery Formats
  • Pdf and market estimation excel
  • Free customization (Pre-sale)
  • 20% Free customization
  • Analyst hour support (Post Sale)
  • 8 hour
  • Customized notification (newly published)
  • Free report on update (within 180 days)

Request free Sample

SUBMIT REQUEST
Request Custom Report

Request Custom Report

Enquire before buying

Enquire Before Buying

;